<DOC>
	<DOCNO>NCT00630500</DOCNO>
	<brief_summary>A 24-week placebo-controlled parallel group multicentre trial study safety efficacy memantine patient dementia associate Parkinson 's disease dementia Lewy body . It hypothesize memantine safe well tolerate , effective placebo .</brief_summary>
	<brief_title>Efficacy Safety Memantine Parkinson 's Disease Dementia ( PDD ) Dementia With Lewy Bodies ( DLB )</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>diagnosis Parkinson 's disease ( Larsen Dupont , 1994 ) dementia ( DSM IV ( 1987 ; 1994 ) , Dementia Lewy body ( McKeith et al . Neurology 2005 ) mildtomoderate moderate dementia ( i.e . MMSE 1226 , inclusive ) subject give write informed consent subject able willing comply study procedure reliable caregiver ( i.e . relative nurse/nurse assistant see patient least weekly ) brain disease sufficient severity cause dementia mental retardation terminal illness life expectancy short 6 month recent major change health status know epilepsy previous convulsive seizure major depression severe dementia define Minimental State Examination score 12 low moderate severe renal impairment ( i.e . serum creatinine &gt; 1,5 upper limit normal ( ULN ) creatinin clearance &lt; 40ml/minute/1,73 m2 moderate severe heart disease ( NYHA IIIIV ) moderate severe pulmonal disease moderate severe hepatic impairment ( bilirubin transaminase &gt; 2 time ULN woman childbearing potential ( i.e . postmenopausal take contraceptive subject lactate laboratory value ( ) exceed limit normality deem clinically relevant study physician know allergy investigational product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Dementia associate Parkinson 's disease</keyword>
	<keyword>Dementia Lewy body</keyword>
	<keyword>Memantine</keyword>
	<keyword>Placebo-controlled</keyword>
	<keyword>Parallel group</keyword>
</DOC>